Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Wick, W; Weller, M; van den Bent, M; Sanson, M; Weiler, M; von Deimling, A; Plass, C; Hegi, M; Platten, M; Reifenberger, G (2014). MGMT testing-the challenges for biomarker-based glioma treatment. Nature Reviews. Neurology, 10(7):372-85.

Goeppert, B; Schmidt, C R; Geiselhart, L; Dutruel, C; Capper, D; Renner, M; Vogel, M N; Zachskorn, C; Zinke, J; Campos, B; Schmezer, P; Popanda, O; Wick, W; Weller, M; Meyermann, R; Schittenhelm, J; Harter, P N; Simon, P; Weichert, W; Schirmacher, P; Plass, C; Mittelbronn, M (2013). Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Journal of Neuropathology and Experimental Neurology, 72(10):933-941.

Wiestler, B; Claus, R; Hartlieb, S A; Schliesser, M G; Weiss, E K; Hielscher, T; Platten, M; Dittmann, L M; Meisner, C; Felsberg, J; Happold, C; Simon, M; Nikkhah, G; Papsdorf, K; Steinbach, J P; Sabel, M; Grimm, C; Weichenhan, D; Tews, B; Reifenberger, G; Capper, D; Müller, W; Plass, C; Weller, M; Wick, W (2013). Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology, 15(8):1017-1026.

Olk-Batz, C; Poetsch, A R; Nöllke, P; Claus, R; Zucknick, M; Sandrock, I; Witte, T; Strahm, B; Hasle, H; Zecca, M; Stary, J; Bergstraesser, E; De Moerloose, B; Trebo, M; van den Heuvel-Eibrink, M M; Wojcik, D; Locatelli, F; Plass, C; Niemeyer, C M; Flotho, C (2011). Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood, 117(18):4871-4880.

This list was generated on Wed Nov 22 05:40:18 2017 CET.